Antibrillatory effect of some beta-adrenergic receptor blocking agents determined by a new test procedure in mice.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D004562:Electrocardiography; D006846:Hydrocarbons, Halogenated; D008297:Male; D051379:Mice; D013565:Sympatholytics / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D006846:Hydrocarbons, Halogenated; D013565:Sympatholytics